Calcification of a phosphaturic mesenchymal tumor harboring an FN1-FGFR1 fusion was observed in a patient with tumor-induced osteomalacia treated with FGFR inhibitor infigratinib; however, the patient ultimately experienced disease progression and died [10]. Here, FGFR1 is linked to osteomalacia.